1. Home
  2. PTLE vs CARM Comparison

PTLE vs CARM Comparison

Compare PTLE & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTLE
  • CARM
  • Stock Information
  • Founded
  • PTLE 2013
  • CARM 2016
  • Country
  • PTLE Singapore
  • CARM United States
  • Employees
  • PTLE N/A
  • CARM N/A
  • Industry
  • PTLE Oil Refining/Marketing
  • CARM Biotechnology: Pharmaceutical Preparations
  • Sector
  • PTLE Energy
  • CARM Health Care
  • Exchange
  • PTLE Nasdaq
  • CARM Nasdaq
  • Market Cap
  • PTLE 16.4M
  • CARM 16.4M
  • IPO Year
  • PTLE 2024
  • CARM N/A
  • Fundamental
  • Price
  • PTLE $0.22
  • CARM $0.40
  • Analyst Decision
  • PTLE
  • CARM Hold
  • Analyst Count
  • PTLE 0
  • CARM 5
  • Target Price
  • PTLE N/A
  • CARM $0.90
  • AVG Volume (30 Days)
  • PTLE 26.5M
  • CARM 3.2M
  • Earning Date
  • PTLE 02-21-2025
  • CARM 08-07-2025
  • Dividend Yield
  • PTLE N/A
  • CARM N/A
  • EPS Growth
  • PTLE N/A
  • CARM N/A
  • EPS
  • PTLE N/A
  • CARM N/A
  • Revenue
  • PTLE $98,133,646.00
  • CARM $19,964,000.00
  • Revenue This Year
  • PTLE N/A
  • CARM N/A
  • Revenue Next Year
  • PTLE N/A
  • CARM N/A
  • P/E Ratio
  • PTLE N/A
  • CARM N/A
  • Revenue Growth
  • PTLE N/A
  • CARM 32.45
  • 52 Week Low
  • PTLE $0.17
  • CARM $0.14
  • 52 Week High
  • PTLE $15.78
  • CARM $1.38
  • Technical
  • Relative Strength Index (RSI)
  • PTLE N/A
  • CARM 51.42
  • Support Level
  • PTLE N/A
  • CARM $0.38
  • Resistance Level
  • PTLE N/A
  • CARM $0.42
  • Average True Range (ATR)
  • PTLE 0.00
  • CARM 0.03
  • MACD
  • PTLE 0.00
  • CARM -0.01
  • Stochastic Oscillator
  • PTLE 0.00
  • CARM 27.93

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, primarily serving the Asia Pacific market. As a bunker facilitator, the Group's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers in a timely manner; and handling disputes, mainly in relation to quality and quantity issues on marine fuel, if any.

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

Share on Social Networks: